Biotricity, Inc. (NASDAQ:BTCY – Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 487,100 shares, a growth of 5.9% from the July 15th total of 460,000 shares. Based on an average daily trading volume, of 81,400 shares, the short-interest ratio is presently 6.0 days. Approximately 17.0% of the shares of the company are short sold.
Biotricity Stock Performance
NASDAQ BTCY traded up $0.01 during trading on Tuesday, hitting $0.41. 38,224 shares of the company’s stock traded hands, compared to its average volume of 81,869. The stock has a market capitalization of $8.87 million, a price-to-earnings ratio of -0.31 and a beta of 1.39. The business has a 50 day moving average of $0.75 and a 200-day moving average of $1.03. Biotricity has a 12-month low of $0.37 and a 12-month high of $2.43.
Biotricity (NASDAQ:BTCY – Get Free Report) last announced its quarterly earnings results on Thursday, June 27th. The company reported ($0.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.11). The company had revenue of $3.18 million for the quarter, compared to the consensus estimate of $3.20 million. On average, analysts expect that Biotricity will post -0.43 EPS for the current year.
Hedge Funds Weigh In On Biotricity
Biotricity Company Profile
Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
Featured Articles
- Five stocks we like better than Biotricity
- Dividend Payout Ratio Calculator
- Momentum in Palo Alto Networks: Tech Stocks Still Going Strong
- How to Most Effectively Use the MarketBeat Earnings Screener
- Buffett’s Big Bet: Should You Follow Berkshire’s Move on OXY?
- Industrial Products Stocks Investing
- GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.